drugset / Trial / NCT00681889
Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the effectiveness and safety of ranibizumab (Lucentis) in treatment of corneal neovascularization.
Timeline
- Start
- 2008-04
- Primary completion
- 2009-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ranibizumab | Monoclonal antibody | — | Topical |